One of the largest private specialty insurers in the country is heading for the New York Stock Exchange, six years after its PE-backed founders built it from the remnants of a Bermuda-owned runoff platform. Core Specialty Insurance Holdings, Inc. filed a registration statement on Form S-1 with the US Securities and Exchange Commission (SEC), disclosing plans to list under the ticker “CORE” with J.P. Morgan, Goldman Sachs, and BMO Capital Markets leading the offering.
Core Specialty itself is not raising capital. The S-1 states the company will not sell shares and will not receive any proceeds. The offering is entirely by existing stockholders, the private equity firms and institutional investors who backed the 2020 recapitalization. The listing creates a public market through which they can begin to reduce their stakes.
The company describes the principal purpose as creating “a public market for our common stock” and facilitating “future access to the public equity markets.” The S-1 also discloses a previously identified material weakness in internal controls, which Core Specialty said it is working to remediate. Share counts and pricing remain blank. Those will appear in the first S-1 amendment.
Core Specialty was formed in November 2020 when founder Jeff Consolino, formerly chief financial officer of American Financial Group, led a $900 million recapitalization of StarStone US Holdings from Enstar Group. SkyKnight Capital, Dragoneer Investment Group, and Aquiline Capital Partners provided the new equity. Enstar retained a stake in the combined business. As of September 30, Enstar’s holding vehicle, Cavello Bay Reinsurance Limited, held approximately 20% of Core Specialty, with SkyKnight and Dragoneer combined at 43% through a joint holding entity, according to the S-1.
The business has since grown substantially. Gross written premium reached $4.57 billion in 2025, up from $3.48 billion in 2023 and from $457 million in 2020, according to audited figures in the S-1. The company describes itself as the fourth largest pure-play specialty insurer in the US by gross written premium. It operates through 17 divisions across property and short-tail, specialty casualty, and bond, credit, and guarantee lines, writing roughly 70% of its book on an admitted basis and 30% on an excess and surplus lines basis.
The company’s AM Best financial strength ratings are “A” (Excellent) for its primary property and casualty subsidiaries. Its combined ratio for the nine months ended September 30, 2026 was 93.0%, down from 98.2% in the same period a year earlier, according to unaudited interim figures in the S-1. For full-year 2025 the figure was 97.4%, per audited results. Net income was $118.9 million in 2025.
Three wholesale brokers represented 39% of Core Specialty’s gross written premium in the nine months ended September 30. The company acknowledges that consolidation among distribution partners is an ongoing trend and that the loss of a key broker relationship could affect results materially. Going public subjects those dynamics to quarterly scrutiny in a way private ownership does not.
The filing arrives in a window where investor appetite for specialty insurer listings has been active but uneven. Ategrity Specialty filed for an NYSE listing in March 2025, and Orion180 Insurance priced its IPO in September 2026 below its targeted range, raising $240 million against a targeted $15 to $17 price band.
Core Specialty is significantly larger and more diversified than either, but it enters the same investor conversation about how the public market values specialty insurance businesses as the hard market cycle moderates.